UNSPSC 51201810: Galsulfase

This classification denotes an enzyme replacement preparation with the molecular formula C2529H3843N689O716S16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59UA429E5G, more generally known as galsulfase. European Medicines Agency schedules galsulfase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21229. The term GALSULFASE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 19, no. 3, 2005, list 54.

Most nations schedule galsulfase under HS 35079090 and SITC 51691. As of Q4 2014, GALSULFASE remains the US FDA Preferred Term for this commodity. Galsulfase bears US NLM identifiers UMLS ID C1615657 and NCI Concept Code C74207. SMILES: NONE.

UNSPSC 51201810 Galsulfase is a Commodity code that covers specialized pharmaceutical products, though the most recent state and local activity recorded under it involves yellow fever vaccine procurement rather than galsulfase itself. State and local health departments are the primary issuing bodies soliciting under this code, with solicitations focused on vaccines and biologics for public health programs. The scope of work reflects direct acquisition of regulated pharmaceutical products through procurement processes that may be competitive, cooperative, or sole-source in nature, depending on supplier availability and regulatory constraints.

The Mississippi State Department of Health posted a sole source procurement notice on July 13, 2026 (Solicitation 1301-27-R-RFIN-00001) for yellow fever vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026. This notice does not specify quantity, contract term, estimated value, or pricing. The Mississippi posting is the only recent documented state or local opportunity under this code in the source data, limiting visibility into geographic spread or issuing-body concentration. The lack of additional recent opportunities suggests this code experiences sparse activity in state and local procurement overall.